Antios Therapeutics
Antios Therapeutics is a biotech company in Atlanta, United States, founded in 2018. It has raised $96.0M across 1 round, most recently a $96.0M Series B in April 2021.
- Headquarters
- Atlanta, Georgia
- Employees
- 11–50
- Founded
- 2018
- Website
- antiostherapeutics.com
- Total Funding
- $96.0M
- Last Round
- $96.0M Series BApr 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Antios Therapeutics has developed capsid assembly modulators as potential treatments for patients infected with hepatitis B virus.
Summary
It lists 11–50 employees. It has raised $96.0M in total across 1 round, most recently a $96.0M Series B round in Apr 2021.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2021
Similar Companies

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/antios-therapeutics"><img src="https://indexed.vc/api/badge/company/antios-therapeutics" alt="Antios Therapeutics on Indexed.vc" width="260" height="76" /></a>